Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Hepatitis C | Research

Retrospective analysis of vertical Hepatitis C exposure and infection in children in Western New York

Authors: Ndeye Licka Dieye, Mine Varol, Shauna C. Zorich, Amy E. Millen, Karl O. A. Yu, Oscar G. Gómez-Duarte

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Vertical transmission of hepatitis C virus (HCV) is the primary cause of hepatitis C in the pediatric population. Nonetheless, only a small proportion of HCV-exposed children are tested. This study aimed to measure the proportion of HCV-exposed children tested and infected in Western New York and to identify factors influencing the odds of testing and infection in this population.

Methods

This was a 11-year retrospective chart review study in which clinical, demographic, and behavioral data for HCV-exposed children and their mothers were collected. This period included year 2019 when a hepatitis C program began promoting early hepatitis C screening among infants born to mothers positive for hepatitis C. PCR-based detection of hepatitis C was used for children under 18 months of age and antibody testing for children above 18 months of age, followed by PCR if the antibody testing was positive. Logistic regression models were used to determine which characteristics associate with testing and infection status.

Results

From a total of 133 children evaluated in clinic for hepatitis C from 2011 to 2021, 96.2% (128/133) were seen from 2019 to 2021. Among the 133 HCV-exposed children in our sample, 72.1% (96/133) were tested for HCV, 62.4% (83/133) were tested by PCR, 9.0% (12/133) tested by antibody, and 5.2% (5/95) of those tested were infected. Only one child out of 12 was positive for hepatitis C antibody yet, subsequent PCR testing was negative in this child. Among all five hepatitis C infected children, four were diagnosed with neonatal abstinence syndrome, five had maternal history of illicit drug use, one had maternal history of HIV infection, and all of them were identified after the hepatitis C program open in 2019. The odds of a child being tested were lower for those accompanied by their biological mother at their clinic visit (odds ratio, 0.16; 95% CI, 0.06–0.45).

Conclusions

Screening programs on hepatitis C vertical transmission improved detection of hepatitis C among exposed children. The proportion of children born to mothers with hepatitis C in Western New York that were positive for hepatitis C was 5.2%, suggesting that similar proportion of exposed infants born before 2019 were lost for follow up.
Literature
1.
go back to reference Epstein RL, Espinosa C. Hepatitis C Virus in Neonates and Infants. Clin Perinatol. 2021;48:343–57.CrossRefPubMed Epstein RL, Espinosa C. Hepatitis C Virus in Neonates and Infants. Clin Perinatol. 2021;48:343–57.CrossRefPubMed
2.
go back to reference World Health Organization. Global hepatitis report 2017. Geneva: World Health Organization; 2017. World Health Organization. Global hepatitis report 2017. Geneva: World Health Organization; 2017.
3.
go back to reference Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C virus infection: Host–Virus Interaction and Mechanisms of viral persistence. Cells. 2019;8:E376.CrossRef Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C virus infection: HostVirus Interaction and Mechanisms of viral persistence. Cells. 2019;8:E376.CrossRef
5.
go back to reference Syriopoulou V, Nikolopoulou G, Daikos GL, Theodoridou M, Pavlopoulou I, Nicolaidou P, et al. Mother to child transmission of hepatitis C virus: rate of infection and risk factors. Scand J Infect Dis. 2005;37:350–3.CrossRefPubMed Syriopoulou V, Nikolopoulou G, Daikos GL, Theodoridou M, Pavlopoulou I, Nicolaidou P, et al. Mother to child transmission of hepatitis C virus: rate of infection and risk factors. Scand J Infect Dis. 2005;37:350–3.CrossRefPubMed
6.
go back to reference Mast EE, Hwang L-Y, Seto DSY, Nolte FS, Nainan OV, Wurtzel H, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis. 2005;192:1880–9.CrossRefPubMed Mast EE, Hwang L-Y, Seto DSY, Nolte FS, Nainan OV, Wurtzel H, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis. 2005;192:1880–9.CrossRefPubMed
7.
go back to reference Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical Transmission of Hepatitis C Virus: systematic review and Meta-analysis. Clin Infect Dis. 2014;59:765–73.CrossRefPubMedPubMedCentral Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical Transmission of Hepatitis C Virus: systematic review and Meta-analysis. Clin Infect Dis. 2014;59:765–73.CrossRefPubMedPubMedCentral
8.
go back to reference Kimberlin DW, Brady MT. Recommendations for care of children in special circumstances; hepatitis C. Red Book: 2015 Report of the Committee on Infectious Diseases. 2015. Kimberlin DW, Brady MT. Recommendations for care of children in special circumstances; hepatitis C. Red Book: 2015 Report of the Committee on Infectious Diseases. 2015.
9.
go back to reference Mack CL, Gonzalez-Peralta RP, Gupta N, Leung D, Narkewicz MR, Roberts EA, et al. NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents. J Pediatr Gastroenterol Nutr. 2012;54:838–55.CrossRefPubMed Mack CL, Gonzalez-Peralta RP, Gupta N, Leung D, Narkewicz MR, Roberts EA, et al. NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents. J Pediatr Gastroenterol Nutr. 2012;54:838–55.CrossRefPubMed
10.
go back to reference Bhardwaj AM, Mhanna MJ, Abughali NF. Maternal risk factors associated with inadequate testing and loss to follow-up in infants with perinatal hepatitis C virus exposure. NPM. 2021;14:123–9.CrossRef Bhardwaj AM, Mhanna MJ, Abughali NF. Maternal risk factors associated with inadequate testing and loss to follow-up in infants with perinatal hepatitis C virus exposure. NPM. 2021;14:123–9.CrossRef
12.
go back to reference Granovsky MO, Minkoff HL, Tess BH, Waters D, Hatzakis A, Devoid DE, et al. Hepatitis C virus infection in the mothers and Infants Cohort Study. Pediatrics. 1998;102:355–9.CrossRefPubMed Granovsky MO, Minkoff HL, Tess BH, Waters D, Hatzakis A, Devoid DE, et al. Hepatitis C virus infection in the mothers and Infants Cohort Study. Pediatrics. 1998;102:355–9.CrossRefPubMed
13.
go back to reference Kushner T, Park C, Masand D, Wagner B, Grace M, Rosenbluth E, et al. Hepatitis C Seroprevalence among Consecutive Labor and Delivery admissions in two New York City Hospitals. Open Forum Infectious Diseases. 2020;7:ofaa514.CrossRefPubMedPubMedCentral Kushner T, Park C, Masand D, Wagner B, Grace M, Rosenbluth E, et al. Hepatitis C Seroprevalence among Consecutive Labor and Delivery admissions in two New York City Hospitals. Open Forum Infectious Diseases. 2020;7:ofaa514.CrossRefPubMedPubMedCentral
14.
go back to reference Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, et al. Perinatal transmission of Hepatitis C Virus: defining the Cascade of Care. J Pediatr. 2018;203:34–40e1.CrossRefPubMedPubMedCentral Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, et al. Perinatal transmission of Hepatitis C Virus: defining the Cascade of Care. J Pediatr. 2018;203:34–40e1.CrossRefPubMedPubMedCentral
15.
go back to reference Watts T, Stockman L, Martin J, Guilfoyle S, Vergeront JM. Increased risk for mother-to-infant transmission of Hepatitis C Virus among Medicaid Recipients - Wisconsin, 2011–2015. MMWR Morb Mortal Wkly Rep. 2017;66:1136–9.CrossRefPubMedPubMedCentral Watts T, Stockman L, Martin J, Guilfoyle S, Vergeront JM. Increased risk for mother-to-infant transmission of Hepatitis C Virus among Medicaid Recipients - Wisconsin, 2011–2015. MMWR Morb Mortal Wkly Rep. 2017;66:1136–9.CrossRefPubMedPubMedCentral
16.
go back to reference Polywka S, Pembrey L, Tovo P-A, Newell M-L. Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. J Med Virol. 2006;78:305–10.CrossRefPubMed Polywka S, Pembrey L, Tovo P-A, Newell M-L. Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. J Med Virol. 2006;78:305–10.CrossRefPubMed
17.
18.
go back to reference Indolfi G, Mangone G, Bartolini E, Moriondo M, Azzari C, Resti M. Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child. Lancet. 2016;387:1967–8.CrossRefPubMed Indolfi G, Mangone G, Bartolini E, Moriondo M, Azzari C, Resti M. Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child. Lancet. 2016;387:1967–8.CrossRefPubMed
19.
go back to reference England K, Thorne C, Newell M-L. Vertically acquired paediatric coinfection with HIV and hepatitis C virus. Lancet Infect Dis. 2006;6:83–90.CrossRefPubMed England K, Thorne C, Newell M-L. Vertically acquired paediatric coinfection with HIV and hepatitis C virus. Lancet Infect Dis. 2006;6:83–90.CrossRefPubMed
20.
go back to reference Elrazek A, Amer M, El-Hawary B, Salah A, Bhagavathula AS, Alboraie M, et al. Prediction of HCV vertical transmission: what factors should be optimized using data mining computational analysis. Liver Int. 2017;37:529–33.CrossRefPubMed Elrazek A, Amer M, El-Hawary B, Salah A, Bhagavathula AS, Alboraie M, et al. Prediction of HCV vertical transmission: what factors should be optimized using data mining computational analysis. Liver Int. 2017;37:529–33.CrossRefPubMed
21.
go back to reference Delotte J, Barjoan EM, Berrébi A, Laffont C, Benos P, Pradier C, et al. Obstetric management does not influence vertical transmission of HCV infection: results of the ALHICE group study. J Matern Fetal Neonatal Med. 2014;27:664–70.CrossRefPubMed Delotte J, Barjoan EM, Berrébi A, Laffont C, Benos P, Pradier C, et al. Obstetric management does not influence vertical transmission of HCV infection: results of the ALHICE group study. J Matern Fetal Neonatal Med. 2014;27:664–70.CrossRefPubMed
22.
go back to reference Ghamar Chehreh ME, Tabatabaei SV, Khazanehdari S, Alavian SM. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis. Arch Gynecol Obstet. 2011;283:255–60.CrossRefPubMed Ghamar Chehreh ME, Tabatabaei SV, Khazanehdari S, Alavian SM. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis. Arch Gynecol Obstet. 2011;283:255–60.CrossRefPubMed
23.
go back to reference Varol M, Licka Dieye N, Zang M, Handa D, Zorich C, Millen S. Hepatitis C Virus exposure and infection in the Perinatal Period. Curr Pediatr Rev. 2022;19:21–33.PubMed Varol M, Licka Dieye N, Zang M, Handa D, Zorich C, Millen S. Hepatitis C Virus exposure and infection in the Perinatal Period. Curr Pediatr Rev. 2022;19:21–33.PubMed
24.
go back to reference Centers for Disease Control and Prevention. CDC Recommendations for Hepatitis C Testing among perinatally exposed Infants and Children-United States, 2023; request for comment and notice of informational Webinar. Fed Reg. 2022;:71330–2. Centers for Disease Control and Prevention. CDC Recommendations for Hepatitis C Testing among perinatally exposed Infants and Children-United States, 2023; request for comment and notice of informational Webinar. Fed Reg. 2022;:71330–2.
Metadata
Title
Retrospective analysis of vertical Hepatitis C exposure and infection in children in Western New York
Authors
Ndeye Licka Dieye
Mine Varol
Shauna C. Zorich
Amy E. Millen
Karl O. A. Yu
Oscar G. Gómez-Duarte
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02871-8

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine